Recent News

• 07.15.2026 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
• 05.08.2026 - Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American
• 04.28.2026 - Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
• 04.14.2026 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
• 03.12.2026 - Cryo-Cell Receives NYSE American Continued Listing Notice
• 02.27.2026 - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
• 10.15.2025 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
• 08.14.2025 - Cryo-Cell International, Inc. Provides Dividend Update
• 07.15.2025 - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
• 05.08.2025 - Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

Recent Filings

• 07.15.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.07.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.08.2026 - 8-K Current report
• 05.08.2026 - EX-99.1 EX-99.1
• 04.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 03.25.2026 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 03.12.2026 - 8-K Current report
• 03.12.2026 - EX-99.1 EX-99.1
• 02.27.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]